Table 1.
Test Performance Characteristics (Serial Alpha-fetoprotein, Age, Alanine Aminotransferase, and Platelets) Model Estimated 6-month HCC Probabilities at Various Risk Thresholds Generated by the Model
| Predicted HCC Probability Threshold (%) | Sensitivity (%) | Specificity (%) | NPV (%) | PPV (%) |
|---|---|---|---|---|
| 4 | 68.2 | 83.3 | 98.4 | 14.5 |
| 10 | 49.5 | 96.0 | 97.9 | 34.1 |
| 20 | 40.0 | 98.4 | 97.5 | 51.1 |
| 30 | 36.0 | 99.1 | 97.4 | 61.1 |
| 40 | 31.0 | 99.4 | 97.2 | 66.7 |
| 50 | 26.4 | 99.5 | 97.0 | 70.6 |
| 60 | 21.5 | 99.68 | 96.8 | 73.5 |
| 70 | 16.3 | 99.8 | 96.6 | 77.6 |
| 80 | 10.2 | 99.9 | 96.4 | 82.8 |
| 90 | 4.9 | 99.9 | 96.2 | 87.1 |
HCC, hepatocellular carcinoma; NPV, negative predictive value; PPV, positive predictive value.